Levels of tenofovir-diphosphate, or TFV-DP, in dried blood spots were 31% to 37% lower among African pregnant adolescent girls and young women taking pre-exposure prophylaxis, or PrEP, compared with those who were postpartum, according to study findings from the IMPAACT 2009 trial presented during CROI.